Psychotherapy of Generalized Anxiety Disorder

German Research Foundation70 enrolled

Overview

The purpose of this study is to compare the effects of worry exposure with the effects of applied relaxation in patients with generalized anxiety disorder.

Controlled treatment studies show that there is a lower efficacy of cognitive-behavioral treatment of generalized anxiety disorder (GAD) than in other anxiety disorders. The best effect sizes are found for applied relaxation (Öst), but there are only three treatment studies. Another, yet previously not tested in its pure form, approach is "worry-exposure", which aims at confronting the emotionally intensive imaginative contents of worries in GAD. Fifty-two randomized patients with GAD as a primary diagnosis will be treated with one of the two treatments and will be compared with waiting-list patients. This treatment protocol contains 15 sessions (+/-2) and a 6 month and 12 month follow-up. The comparisons in this study include: worry exposure versus applied relaxation versus a waiting control group.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Anxiety Disorders

Interventions

Worry exposureBEHAVIORAL

Applied relaxationBEHAVIORAL

Eligibility

Sex: ALLMin age: 18 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Primary Diagnosis of generalized anxiety disorder (according to impairment) * 18-70 years of age * Informed consent Exclusion Criteria: * Not able to understand and speak the German language * Acute, unstable and severe somatic disease (DSM-IV, Axis III) * History of schizophrenia or bipolar disorder * Other mental disorders requiring treatment * Substance dependence within the past 12 months preceding treatment * Personality disorders that interfere with treatment compliance * Participation in any other psychotherapeutic interventions * Use of anxiolytics (e.g. tranquilizer, hypnotics, neuroleptics; does not include stabile use of antidepressants)

Locations (1)

Technische Universität Dresden

Dresden, Germany

Outcomes

Primary Outcomes

At post-treatment: anxiety (Hamilton Anxiety Rating Scale, HARS), depression (Hamilton Depression Scale, HAM-D), trait-anxiety (State-Trait-Anxiety Inventory, STAI-T)

At 6-month follow-up: M-CIDI (Composite International Diagnostic Interview, generalized anxiety disorder section)

Secondary Outcomes

At post-treatment, 6 and 12 month follow-ups:

worry (Penn State Worry Questionnaire, PSWQ)

general symptoms (Brief Symptom Inventory, BSI)

depression (Beck Depression Inventory, BDI)

interpersonal problems (Inventory of Interpersonal Problems - IIP)

meta-cognitions (Meta Cognitions Questionnaire)

thought suppression (White Bear Suppression Inventory) tolerance for uncertainty (Ungewissheitstoleranzskala, UGTS)

positive and negative affect (Positive and Negative Affect Schedule, PANAS)

At post-treatment: behavior assessment tests

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.